A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
ALX Oncology Inc.
ALX Oncology Inc.
Mayo Clinic
GlaxoSmithKline
National Cancer Institute (NCI)
Celldex Therapeutics
OHSU Knight Cancer Institute
Corvus Pharmaceuticals, Inc.
Seagen Inc.
Merck Sharp & Dohme LLC